Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Probenecid | The serum concentration of Cefozopran can be increased when it is combined with Probenecid. |
| Foscarnet | The risk or severity of nephrotoxicity can be increased when Cefozopran is combined with Foscarnet. |
| Mannitol | The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cefozopran. |
| Tenofovir disoproxil | Cefozopran may increase the nephrotoxic activities of Tenofovir disoproxil. |
| Tenofovir alafenamide | Cefozopran may increase the nephrotoxic activities of Tenofovir alafenamide. |
| Tenofovir | Cefozopran may increase the nephrotoxic activities of Tenofovir. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefozopran. |
| Cyclosporine | The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefozopran. |
| Icosapent | The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Cefozopran. |
| Cefotiam | The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefozopran. |
| Mesalazine | The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefozopran. |
| Cefmenoxime | The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Cefozopran. |
| Cefmetazole | The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cefozopran. |
| Indomethacin | The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefozopran. |
| Triamterene | The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefozopran. |
| Cefpiramide | The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Cefozopran. |
| Loracarbef | The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefozopran. |
| Cefalotin | The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Cefozopran. |
| Nabumetone | The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefozopran. |
| Ketorolac | The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefozopran. |
| Tenoxicam | The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefozopran. |
| Celecoxib | The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cefozopran. |
| Cefotaxime | The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefozopran. |
| Tolmetin | The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cefozopran. |
| Rofecoxib | The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cefozopran. |
| Fenoprofen | The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Cefozopran. |
| Valdecoxib | The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefozopran. |
| Diclofenac | The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Cefozopran. |
| Sulindac | The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Cefozopran. |
| Bacitracin | The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Cefozopran. |
| Amphotericin B | The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefozopran. |
| Cephaloglycin | The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Cefozopran. |
| Adefovir dipivoxil | The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Cefozopran. |
| Pentamidine | The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Cefozopran. |
| Mefenamic acid | The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Cefozopran. |
| Naproxen | The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefozopran. |
| Sulfasalazine | The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefozopran. |
| Phenylbutazone | The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Cefozopran. |
| Meloxicam | The risk or severity of methemoglobinemia can be increased when Cefozopran is combined with Meloxicam. |
| Carprofen | The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Cefozopran. |
| Tacrolimus | The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Cefozopran. |
| Etacrynic acid | The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Cefozopran. |
| Ceforanide | The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Cefozopran. |
| Salicylic acid | The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Cefozopran. |
| Acetylsalicylic acid | The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefozopran. |
| Hydrochlorothiazide | The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefozopran. |
| Balsalazide | The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Cefozopran. |
| Cefditoren | The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Cefozopran. |
| Atazanavir | The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefozopran. |
| Colistimethate | The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Cefozopran. |
| Cefuroxime | The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Cefozopran. |
| Cefapirin | The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Cefozopran. |
| Cefprozil | The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Cefozopran. |
| Olsalazine | The risk or severity of nephrotoxicity can be increased when Cefozopran is combined with Olsalazine. |
| Lumiracoxib | The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Cefozopran. |
| Cefamandole | The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Cefozopran. |
| Cefazolin | The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefozopran. |
| Cefonicid | The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Cefozopran. |
| Cefoperazone | The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Cefozopran. |
| Cefoxitin | The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Cefozopran. |
| Ceftizoxime | The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Cefozopran. |
| Magnesium salicylate | The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Cefozopran. |
| Salsalate | The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Cefozopran. |
| Choline magnesium trisalicylate | The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefozopran. |
| Cefepime | The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cefozopran. |
| Cefacetrile | The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Cefozopran. |
| Cefpodoxime | The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Cefozopran. |
| Antrafenine | The risk or severity of nephrotoxicity can be increased when Antrafenine is combined with Cefozopran. |
| Aminophenazone | The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Cefozopran. |
| Antipyrine | The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Cefozopran. |
| Tiaprofenic acid | The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Cefozopran. |
| Lopinavir | The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Cefozopran. |
| Etoricoxib | The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Cefozopran. |
| Hydrolyzed Cephalothin | The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Cefozopran. |
| Cephalothin Group | The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Cefozopran. |
| Oxyphenbutazone | The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefozopran. |
| Latamoxef | The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Cefozopran. |
| Nimesulide | The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Cefozopran. |
| Benoxaprofen | The risk or severity of nephrotoxicity can be increased when Benoxaprofen is combined with Cefozopran. |
| Metamizole | The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Cefozopran. |
| Zomepirac | The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Cefozopran. |
| Ceftobiprole | The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Cefozopran. |
| Cimicoxib | The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Cefozopran. |
| Ceftaroline fosamil | The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Cefozopran. |
| Lornoxicam | The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Cefozopran. |
| Zaltoprofen | The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Cefozopran. |
| Azapropazone | The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Cefozopran. |
| Parecoxib | The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Cefozopran. |
| Salicylamide | The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Cefozopran. |
| Kebuzone | The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Cefozopran. |
| Isoxicam | The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Cefozopran. |
| Indoprofen | The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Cefozopran. |
| Ibuproxam | The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Cefozopran. |
| Floctafenine | The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Cefozopran. |
| Fenbufen | The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefozopran. |
| Etofenamate | The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Cefozopran. |
| Epirizole | The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Cefozopran. |
| Cefaloridine | The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Cefozopran. |
| Cefminox | The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Cefozopran. |
| Dexibuprofen | The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefozopran. |